Bradykinin B1 receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S275000, C544S310000, C544S318000, C544S320000, C544S321000, C544S324000, C544S326000, C544S328000, C544S331000

Reexamination Certificate

active

06919347

ABSTRACT:
Bradykinin B1-receptor antagonists of formulaare disclosed. The compounds are useful for treating diseases associated with inappropriate bradykinin receptor activity, such as diabetic vasculopathy, inflammation, pain, hyperalgesia, asthma, rhinitis, septic shock, atherosclerosis and multiple sclerosis. Pyrimidines, triazines, and anilines in which Q is imidazolyl or pyrrolyl are particularly preferred.

REFERENCES:
patent: 3707560 (1972-12-01), DeAngelis
patent: 6432947 (2002-08-01), Arnaiz et al.
patent: 6670473 (2003-12-01), Arnaiz et al.
patent: 2002/0165203 (2002-11-01), Arnaiz et al.
patent: 2002/0183323 (2002-12-01), Arnaiz et al.
patent: 2003/0004137 (2003-01-01), Arnaiz et al.
patent: 2003/0027794 (2003-02-01), Arnaiz et al.
patent: 2003/0060452 (2003-03-01), Arnaiz et al.
patent: 2003/0069210 (2003-04-01), Arnaiz et al.
patent: 2003/0073669 (2003-04-01), Arnaiz et al.
patent: 2003/0083332 (2003-05-01), Arnaiz et al.
patent: 2003/0092678 (2003-05-01), Arnaiz et al.
patent: 0096657 (1983-12-01), None
patent: 0864567 (1998-09-01), None
patent: WO97/24349 (1997-07-01), None
patent: WO98/37079 (1998-08-01), None
patent: WO98/42672 (1998-10-01), None
patent: WO 01/14371 (2001-03-01), None
Kharitonov et al. Eur. Respir. J. 14(5): 1023-1027, 1999.
Bagate et al., Br. J. Pharmacol. 128(8) : 1643-1650.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Bradykinin B1 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bradykinin B1 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bradykinin B1 receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3387967

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.